Skip to content

Clinical trials

Phase 3 Crohn Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: Australia Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20062
20071
20082
20092
20103
20116
20131
20153
20164
20176
20189
20192
20202
20222
20231
20245
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated15
Recruiting8
Active, not recruiting7
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie8
Celgene7
Janssen Research & Development, LLC7
Takeda5
GlaxoSmithKline4
Shire3
Eli Lilly and Company2
Genzyme, a Sanofi Company2
Hoffmann-La Roche2
Lakefront Biotherapeutics NV2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease58
Inflammatory Bowel Diseases7
Colitis, Ulcerative5
Colitis3
Arthritis, Juvenile1
Arthritis, Psoriatic1
Gastroenteritis1
Irritable Bowel Syndrome1

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.